Association of the interleukin (IL)-16 gene polymorphisms with Graves' disease

Clinical Immunology

Volumn 127, Issue 3, 2008, Pages 298-302

  Gu, Xue Jiang ^a,b   Cui, Bin ^a   Zhao, Ze Fei ^a   Chen, Hao Yan ^a   Li, Xiao Ying ^a,c   Wang, Shu ^a   Ning, Guang ^a,c   Zhao, Yong Ju ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b THE FIRST AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Graves'disease; IL 16; Polymorphism

Indexed keywords

CYTOKINE; INTERLEUKIN 16;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; FEMALE; FIBROBLAST; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GRAVES DISEASE; HAPLOTYPE; HELPER CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORBIT; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HUMANS; INTERLEUKIN-16; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 45449092111     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.01.017     Document Type: Article

References (27)

1. Vaidya B., Kendall-Taylor P., and Pearce S.H.S. The genetics of autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 87 (2002) 5385
2. Btix T.H., Kyvik K.O., Christensen K., and Hegedus L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab. 86 (2001) 930
3. Tezuka H., Eguchi K., Fukuda T., Otsubo T., Kawabe Y., Ueki Y., Matsunaga M., Shimomura C., Nakao H., and shikawa N.I. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease. J. Clin. Endocrinol. Metab. 66 (1988) 702
4. Tötterman T.H., Andersson L.C., and Häyry P. Evidence for thyroid antigen reactive T lymphocytes infiltrating the thyroid gland in Graves' disease. Clin. Endocrinol 11 (1979) 59
5. Moser B., Wolf M., Walz A., and Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends. Immunol. 25 (2004) 75
6. Kim H.S. Assignment of human interleukin 16 (IL16) to chromosome 15q26.3 by radiation hybrid mapping. Cytogenet. Cell.Genet 84 (1999) 93
7. Cruikshank W.W., Center D.M., Nisar N., Wu M., Natke B., Theodore A.C., and Kornfeld H. Molecular and functional analysis of a lymphocyte chemoattractant factor: associations of biologic function with CD4 expression. Proc. Natl. Acad. Sic 91 (1994) 510
8. Baier M., Bannert N., Werner A., Lang K., and Kurth R. Molecular cloning, sequence and processing of the interleukin 16 precursor. Proc. Natl. Acad Sic 94 (1997) 273
9. Drwinga H.L., Toji L.H., Kim C.H., Greene A.E., and Mulivor R.A. NIGMS human/rodent somatic cell hybrid mapping panels 1 and 2. Genomics 16 (1993) 311
10. Zhang Y., Center D.M., Wu D.M., Cruikshank W.W., Yuan J., Andrews D.W., and Kornfeld H. Processing and activation of pro-interleukin-16 by caspase-3. J. Biol. Chem. 273 (1998) 1144
11. Center D.M., Kornfeld H., and Cruikshank W.W. Interleukin 16 and its function as aCD4 ligand. Immunol. Today 17 (1996) 476
12. Mathy N.L., Scheuer W., Lanzendörfer M., Honold K., Ambrosius D., Norley S., and Kurth R. Interleukin-16 stimulates the expression and production of pro-inflammatory cytokines by human monocytes. Immunology 100 (2000) 63
13. Laberge S., Ernst P., Ghaffar O., Cruikshank W.W., Kornfeld H., Center D.M., and Hamid Q. Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma. Am. J. Respir. Cell. Mol. Biol. 17 (1997) 193
14. Blaschke S., Schulz H., Schwarz G., Blaschke V., Müller G.A., and Reuss-Borst M. Interleukin-16 expression in relation to disease activity in rheumatoid arthritis. J. Rheumatol. 28 (2001) 12
15. Schreiber S. Monocytes or T cells in Crohn's disease: does IL-16 allow both to play at that game?. Gut 49 (2001) 747
16. Pritchard J., Horst N., Cruikshank W., and Smith T.J. Igs from patients with Graves' disease induce the exression of T cell chemoattractants in their fibroblasts. J. Immunol. 168 (2002) 942
17. Pritchard J., Han R., Horst N., Cruikshank W.W., and Smith T.J. Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. J. Immunol. 170 (2003) 6348
18. Nakayama E.E., Wasi C., Ajisawa A., Iwamoto A., and Shioda T. New polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes. Immun. 1 (2000) 293
19. Glas J., Török H.P., Unterhuber H., Radlmayr M., and Folwaczny C. The - 295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin. Immunol. 106 (2003) 197
20. Folwaczny M., Glas J., Török H.P., Tonenchi L., Paschos E., Malachova O., Bauer B., and Folwaczny C. Prevalence of the - 295 T-to-C promoter polymorphism of the interleukin (IL)-16 gene in periodontitis. Clin. Exp. Immunol. 142 (2005) 188
21. Burkart K.M., Barton S.J., Holloway J.W., Yang I.A., Cakebread J.A., Cruikshank W., Little F., Jin X., Farrer L.A., Clough J.B., Keith T.P., Holgate S., Center D.M., and O'Connor G.T. Association of asthma with a functional promoter polymorphism in the IL16 gene. J. Allergy. Clin. Immunol. 117 (2006) 86
22. Meller J., Jauho A., Hüfner M., Gratz S., and Becker W. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay. Thyroid 10 (2000) 1073.
23. Werner S.C. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J. Clin. Endocrinol. Metab. 44 (1977) 203.
24. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263.
25. Solé X., Guinó E., Valls J., Iniesta R., and Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics 22 (2006) 1928
26. Conne B., Stutz A., and Vassalli J.D. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat. Med. 6 (2000) 637
27. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15